S&P 500   5,130.95 (-0.12%)
DOW   38,989.83 (-0.25%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
S&P 500   5,130.95 (-0.12%)
DOW   38,989.83 (-0.25%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
S&P 500   5,130.95 (-0.12%)
DOW   38,989.83 (-0.25%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
S&P 500   5,130.95 (-0.12%)
DOW   38,989.83 (-0.25%)
QQQ   444.02 (-0.36%)
AAPL   175.10 (-2.54%)
MSFT   414.92 (-0.14%)
META   498.19 (-0.82%)
GOOGL   133.35 (-2.76%)
AMZN   177.58 (-0.36%)
TSLA   188.14 (-7.16%)
NVDA   852.37 (+3.60%)
NIO   5.35 (-7.44%)
AMD   205.36 (+1.34%)
BABA   72.00 (-3.51%)
T   16.80 (-1.06%)
F   12.74 (+2.33%)
MU   95.77 (+0.65%)
CGC   3.02 (-5.92%)
GE   161.04 (+1.51%)
DIS   113.69 (+1.55%)
AMC   4.32 (-0.92%)
PFE   25.89 (-2.63%)
PYPL   59.98 (-0.93%)
XOM   104.36 (-1.40%)
NASDAQ:ALHC

Alignment Healthcare (ALHC) Stock Price, News & Analysis

$5.40
-0.24 (-4.26%)
(As of 03/4/2024 ET)
Today's Range
$5.36
$5.75
50-Day Range
$5.64
$9.00
52-Week Range
$4.88
$9.20
Volume
1.44 million shs
Average Volume
843,416 shs
Market Capitalization
$1.02 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.58

Alignment Healthcare MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.71 Rating Score
Upside/​Downside
96.0% Upside
$10.58 Price Target
Short Interest
Healthy
4.32% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.31mentions of Alignment Healthcare in the last 14 days
Based on 27 Articles This Week
Insider Trading
Selling Shares
$19,752 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.60) to ($0.45) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.04 out of 5 stars

Medical Sector

410th out of 948 stocks

Hospital & Medical Service Plans Industry

7th out of 11 stocks


ALHC stock logo

About Alignment Healthcare Stock (NASDAQ:ALHC)

Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, Nevada, Arizona, Florida, and Texas. The company was founded in 2013 and is based in Orange, California.

ALHC Stock Price History

ALHC Stock News Headlines

Alignment Healthcare (NASDAQ:ALHC) Trading Down 4.2%
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Q4 2023 Alignment Healthcare Inc Earnings Call
Alignment Healthcare: Q4 Earnings Insights
Alignment Healthcare Inc.
ALHC Mar 2024 5.000 put
The Analyst Verdict: Alignment Healthcare In The Eyes Of 5 Experts
See More Headlines
Receive ALHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alignment Healthcare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/27/2024
Today
3/04/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Hospital & medical service plans
Sub-Industry
N/A
Current Symbol
NASDAQ:ALHC
Fax
N/A
Employees
1,536
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$10.58
High Stock Price Target
$12.00
Low Stock Price Target
$7.25
Potential Upside/Downside
+96.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.71
Research Coverage
7 Analysts

Profitability

Net Income
$-148,020,000.00
Pretax Margin
-8.13%

Debt

Sales & Book Value

Annual Sales
$1.82 billion
Book Value
$0.84 per share

Miscellaneous

Free Float
177,072,000
Market Cap
$1.02 billion
Optionable
Optionable
Beta
1.35
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report














ALHC Stock Analysis - Frequently Asked Questions

Should I buy or sell Alignment Healthcare stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Alignment Healthcare in the last twelve months. There are currently 3 hold ratings, 3 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" ALHC shares.
View ALHC analyst ratings
or view top-rated stocks.

What is Alignment Healthcare's stock price target for 2024?

7 analysts have issued twelve-month target prices for Alignment Healthcare's shares. Their ALHC share price targets range from $7.25 to $12.00. On average, they anticipate the company's stock price to reach $10.58 in the next year. This suggests a possible upside of 96.0% from the stock's current price.
View analysts price targets for ALHC
or view top-rated stocks among Wall Street analysts.

How have ALHC shares performed in 2024?

Alignment Healthcare's stock was trading at $8.61 at the start of the year. Since then, ALHC shares have decreased by 37.3% and is now trading at $5.40.
View the best growth stocks for 2024 here
.

Are investors shorting Alignment Healthcare?

Alignment Healthcare saw a drop in short interest in February. As of February 15th, there was short interest totaling 4,100,000 shares, a drop of 5.1% from the January 31st total of 4,320,000 shares. Based on an average daily volume of 627,300 shares, the days-to-cover ratio is presently 6.5 days. Currently, 4.3% of the shares of the stock are sold short.
View Alignment Healthcare's Short Interest
.

When is Alignment Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our ALHC earnings forecast
.

How were Alignment Healthcare's earnings last quarter?

Alignment Healthcare, Inc. (NASDAQ:ALHC) posted its quarterly earnings data on Tuesday, February, 27th. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.22) by $0.03. The firm had revenue of $465.39 million for the quarter, compared to the consensus estimate of $444.56 million. Alignment Healthcare had a negative trailing twelve-month return on equity of 75.64% and a negative net margin of 8.12%. The firm's revenue for the quarter was up 28.6% compared to the same quarter last year. During the same period last year, the business earned ($0.31) earnings per share.

What guidance has Alignment Healthcare issued on next quarter's earnings?

Alignment Healthcare updated its first quarter 2024 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $590.0 million-$600.0 million, compared to the consensus revenue estimate of $550.8 million.

When did Alignment Healthcare IPO?

(ALHC) raised $490 million in an initial public offering on Friday, March 26th 2021. The company issued 27,200,000 shares at $17.00-$19.00 per share. Goldman Sachs, Morgan Stanley, J.P. Morgan, BofA Securities and William Blair served as the underwriters for the IPO and UBS Investment Bank, Piper Sandler and Raymond James were co-managers.

Who are Alignment Healthcare's major shareholders?

Alignment Healthcare's stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (4.84%), Brown Advisory Inc. (1.98%), Price T Rowe Associates Inc. MD (0.57%), Price T Rowe Associates Inc. MD (0.57%), Rhenman & Partners Asset Management AB (0.50%) and Northern Trust Corp (0.43%). Insiders that own company stock include Atlantic (Aln Hlth) L General, Christopher J Joyce, Dawn Christine Maroney, Dinesh M Kumar, Donald Steven Furman, Jeffrey H Margolis, John E Kao, Joseph S Konowiecki, Michael Curtis Foster, Richard A Cross, Robert Thomas Freeman, Warburg Pincus Llc and Warburg Pincus Partners Gp Llc.
View institutional ownership trends
.

How do I buy shares of Alignment Healthcare?

Shares of ALHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ALHC) was last updated on 3/4/2024 by MarketBeat.com Staff